The global targeted cancer therapies market is estimated to be valued at US$ 1603.7 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |